Compare AIV & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIV | NEOG |
|---|---|---|
| Founded | 1975 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1994 | 1989 |
| Metric | AIV | NEOG |
|---|---|---|
| Price | $5.74 | $7.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $8.83 |
| AVG Volume (30 Days) | 1.6M | ★ 3.6M |
| Earning Date | 11-10-2025 | 01-09-2026 |
| Dividend Yield | ★ 49.30% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.72 | N/A |
| Revenue | $210,889,000.00 | ★ $886,886,000.00 |
| Revenue This Year | $6.96 | N/A |
| Revenue Next Year | N/A | $1.80 |
| P/E Ratio | $3.64 | ★ N/A |
| Revenue Growth | ★ 39.67 | N/A |
| 52 Week Low | $5.24 | $3.87 |
| 52 Week High | $9.29 | $13.41 |
| Indicator | AIV | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 71.75 |
| Support Level | $5.58 | $5.82 |
| Resistance Level | $5.62 | $6.08 |
| Average True Range (ATR) | 0.07 | 0.30 |
| MACD | 0.04 | 0.12 |
| Stochastic Oscillator | 89.47 | 99.13 |
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.